Skip to main content

Find Clinical Trials

Home
Conditions
Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor

Clinical trial condition

Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor

Explore clinical trials studying Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor trial results

Completed

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer

NCT03711058

Conditions: Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +24 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details